Status:
COMPLETED
IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Hypertension
Eligibility:
All Genders
25-60 years
Phase:
PHASE4
Brief Summary
The principal scientific objective of the trial is to identify the factors that are associated with differential blood pressure responses between drugs. This may allow investigators to produce new hyp...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Participants have to be 25 to 60 years of age
- Both genders
- Systolic blood pressure of 140 mmHg or above; diastolic blood pressure of 90 mmHg or above.
- Cardiovascular risk must not be high, to allow for two periods of 4 weeks of placebo without ethical concern.
Exclusion
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT00128518
Start Date
October 1 2004
End Date
September 1 2010
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Louis Pradel
Bron, France, 69677